The Asian Pacific Association for the Study of the Liver [APASL]

Theme	Full process management of liver transplant patients
Dates	November 1-2, 2025
City	Qingdao, China
President	Dr. Jinzhen Cai
URL	To be announced.

Theme	MAFLD and Metabolic Complications: Applying Multidisciplinary Solutions
Dates	December 6-7, 2025
City	Karachi, Pakistan
President	Dr. Amna Subhan Butt
URL	To be announced.

Theme	Current Management of HCC with Local Relevance
Dates	December 13-14, 2025
City	Yangon, Myanmar
President	Dr. Kyaw Soe Tun
URL	To be announced.

Theme	Combination therapy for advanced HCC
Dates	January 17-18, 2026
City	New Delhi, India
President	Dr. Manoj Sharma

Theme	Wilson Disease : New Concepts in Diagnosis and Management
Dates	January 30-31, 2026
City	New Delhi, India
President	Dr. Seema Alam

Theme	Treatment Dynamics of Liver Tumors
Dates	April 2-3, 2026
City	Tokyo, Japan
President	Dr. Shuntaro Obi
URL	https://www.apasl-oncology2026tokyo.org

Theme	Clinical Application of Liver Imaging in A.I. Era
Dates	June, 2026
City	Guangzhou, China
President	Dr. Jinjun Chen
URL	To be announced.

Theme	Aetiology Specific Considerations in Optimizing Care of the Cirrhotic Patient
Dates	July, 2026
City	Singapore, Singapore
President	Dr. Mark Muthiah
URL	To be announced.

Theme	Liver Cancer Control – Ending Hepatitis, Halting MASLD-MAFLD
Dates	September 18-19, 2026
City	Kumamoto, Japan
President	Dr. Yasuhito Tanaka
URL	https://www.apasl-stc2026kumamoto.org

What's New

2025/10/24
The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes.

The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes. This … [Read more]
2025/10/23
This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities.

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), … [Read more]
2025/10/21
Do the therapeutic vaccines hold hope for the treatment of hepatitis B ?

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), … [Read more]
2025/10/20
Please check out the latest article on Hep I !!

Understanding the stage-specific impact of portal hypertension is crucial in optimizing surgical outcomes for hepatocellular carcinoma (HCC). This study provides … [Read more]
2025/10/17
APASL STC 2025 Yangon will be held on December 13-14 !!

Please check out the Scientific Program of APASL STC 2025 Yangon scheduled on December 13-14 !! We are so thrilled … [Read more]